ascorbic acid - Profile
✉ Email this page to a colleague
What are the generic sources for ascorbic acid and what is the scope of patent protection?
Ascorbic acid
is the generic ingredient in eighteen branded drugs marketed by Mcguff, Fresenius Kabi Usa, Stira, Sandoz Canada Inc, Apotex, Hospira, Roche, Abraxis Pharm, Watson Labs, Teligent, Salix Pharms, Novel Labs Inc, Taro, and Salix, and is included in nineteen NDAs. There are eleven patents protecting this compound. Additional information is available in the individual branded drug profile pages.Summary for ascorbic acid
| US Patents: | 11 |
| Tradenames: | 18 |
| Applicants: | 13 |
| NDAs: | 18 |
US Patents and Regulatory Information for ascorbic acid
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mcguff | ASCOR | ascorbic acid | SOLUTION;INTRAVENOUS | 209112-001 | Oct 2, 2017 | AP | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Fresenius Kabi Usa | ASCORBIC ACID | ascorbic acid | SOLUTION;INTRAVENOUS | 217131-001 | Aug 7, 2025 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Stira | ASCORBIC ACID | ascorbic acid | SOLUTION;INTRAVENOUS | 220172-001 | Jul 30, 2026 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
